| Michael Garcia, MD | |
|
14350 Meridian Pkwy # 2, Riverside, CA 92518-3035 | |
| (818) 826-3503 | |
| Not Available |
| Full Name | Michael Garcia |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 14350 Meridian Pkwy # 2, Riverside, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891314464 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | A176743 (California) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | A176743 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael Garcia, MD 14350 Meridian Pkwy # 2, Riverside, CA 92518-3035 Ph: (818) 826-3503 | Michael Garcia, MD 14350 Meridian Pkwy # 2, Riverside, CA 92518-3035 Ph: (818) 826-3503 |
News Archive
A study in the June 1 issue of Cancer Research presents the first evidence that exposure to low doses of environmental estrogens during development of the prostate gland in the male fetus may result in a predisposition to prostate cancer later in life.
Women in rural communities experience higher rates of life-threatening complications during or after childbirth than mothers in urban cities, a new study finds.
Building on its existing foundation of clinical and public policies, the American College of Physicians announced plans to provide physicians and patients with evidence-based recommendations for specific interventions for a variety of clinical problems.
AGA Medical Holdings, Inc. today announced first patient enrollment in the feasibility phase of the prospective, multicenter, randomized AMPLATZER® Cardiac Plug clinical trial. Dr. William Nicholson, an interventional cardiologist and structural heart specialist at York Hospital in Pennsylvania, enrolled the first patient.
Delcath Systems, Inc. today announced that the Company has submitted the remaining modules of its 505(b)(2) New Drug Application (NDA) for its proprietary chemosaturation system to the U.S. Food & Drug Administration (FDA). The Company had previously submitted Module 4, consisting of literature based non-clinical data, to the FDA in late April 2010. The Company is seeking an indication for the percutaneous intra-arterial administration of melphalan hydrochloride for use in the treatment of patients with metastatic melanoma in the liver.
› Verified 9 days ago
Dr. Dalia N Balsamo, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3125 Myers St, Riverside, CA 92503 Phone: 951-358-4840 | |
Dr. David Robert Seigler, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9990 County Farm Rd, Riverside, CA 92503 Phone: 951-358-4881 | |
Richard D Prather, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: Riverside County Dept Of Mental Health, 4095 County Circle Drive, Riverside, CA 92503 Phone: 951-955-8000 Fax: 951-955-8010 | |
Dr. Tokunbo Labisi Williams, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9990 County Farm Rd, Riverside, CA 92503 Phone: 951-358-4770 | |
Monish Parmar, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4095 County Circle Dr, Riverside, CA 92503 Phone: 951-358-4504 | |
Dr. Sahar Hamidy Osman, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4234 Riverwalk Pkwy Ste 230, Riverside, CA 92505 Phone: 951-781-3672 Fax: 951-781-0365 | |
Arthur Amador, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 769 W Blaine St Ste B, Riverside, CA 92507 Phone: 951-358-4705 Fax: 951-358-4719 |